首页 | 本学科首页   官方微博 | 高级检索  
     


Comparison of the clinical efficacy of a new prognostic stratification for duodenal adenocarcinoma with that of TNM staging: The importance of T status with regard to the prognosis
Affiliation:1. Division of Hepatobiliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan;2. Department of Hepatobiliary-Pancreatic Surgery, Graduate School of Medicine, Juntendo University, Tokyo, Japan;1. College of Medicine, SUNY Upstate Medical University, Syracuse, NY;2. Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY;3. Department of Surgery, Division of Surgical Oncology, SUNY Upstate Medical University, Syracuse, NY;1. Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China;2. Gastrointestinal Surgery Center, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, 1095, Jiefang Avenue, Wuhan, Hubei, China;3. Zhongshan People''s Hospital Affiliated to Guangdong Medical University, Guangdong, China;1. Department of Anesthesia, Surgery, and Interventional Radiology, Thyroid Surgery Unit, Head and Neck Oncology Service, Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, France;2. Department of Biology and Pathology, Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, France;3. Department of Radiology, Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, France;4. Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, France
Abstract:BackgroundAlthough the current staging system and therapeutic strategy for duodenal adenocarcinoma (DA) focus on the N status, their validity has not been clarified. In this study, we evaluated the prognostic factors of DA and reviewed the current staging system.MethodsWe included 105 patients who underwent surgical resection of DA in our department between September 2006 and October 2020. Patients with localised disease other than an early tumour (pT1a) were classified into the advanced group, and prognostic factors were compared with those for the Union for International Cancer Control (UICC) classification, 8th edition.ResultsThe 5-year overall survival (OS) rate in the advanced group (n = 55) was 73%. Multivariate analysis revealed that pT4 and pN2 statuses were independent prognostic factors for OS. The prognosis was stratified based on the pT4 and pN2 statuses, whereas the survival curves for patients with pStage II (pN0) and pStage IIIA (pN1) DA overlapped on staging according to the UICC classification. The new classification indicated a favourable prognosis for patients classified as pT1-3N1 stage IIIA (5-year OS, 86%), whereas the prognosis of patients with pT4N0-1 DA was similar to those classified as pT1-3N2 stage IIIB. Patients with pT4N2 DA had a similar prognosis (5-year OS, 24%) as those with metastases, and 75% of these patients showed distant metastasis within one year after surgery.ConclusionBoth T and N statuses affect the prognosis of DA. Patients with pT4N2 DA may require intensive adjuvant chemotherapy. (238 words)
Keywords:CT"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_Q3TFuQlDyH"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  computed tomography  DG"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_vm98CQZdKd"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  distal gastrectomy  DA"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_WOVFyVNYMc"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  duodenal adenocarcinoma  NCCN"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_H01a1Oy7aX"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  National Comprehensive Cancer Network  OS"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_JLC9ZY8Cbz"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  overall survival  PD"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_q3LS6FTqlc"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  pancreatoduodenectomy  PPDD"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_ERdpMDTm2S"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  pancreas-preserving distal duodenectomy  RFS"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_RNI8kofCy1"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  recurrence-free survival  UICC"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  pc_UkaLi4HOLB"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Union for International Cancer Control
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号